ISTH 2021 Congress
Coagulation and Natural Anticoagulants » Contact Pathway
Theme Navigation
- ISTH 2021 Congress
- Coagulation and Natural Anticoagulants
- Contact Pathway
- Coagulation and Natural Anticoagulants
-
Abstract Number: OC 54.1
A Mechanism for Hereditary Angioedema Caused by a plasminogen Lys311Glu Substitution
-
Abstract Number: OC 60.1
A Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating Safety and Efficacy of AB023 in Hemodialysis Patients
-
Abstract Number: PB0074
Extra-terrestrial Soils Activate Coagulation Factor XII and Manage Bleeding in a Porcine Model of Liver Laceration: Implications for Hemorrhage Control during Space Exploration
-
Abstract Number: PB0076
FXI-independent Pathways of Contact Activation: Analysis of Activated Partial Thromboplastin Time (aPTT) Data Using Mathematical Modelling
-
Abstract Number: OC 54.3
Histidine-rich Glycoprotein Attenuates Catheter Thrombosis in Rabbits
-
Abstract Number: PB0077
Pharmacokinetics and Pharmacodynamics of Abelacimab (MAA868), a Novel Dual Inhibitor of Factor XI and Factor XIa
-
Abstract Number: OC 71.1
Pharmacological Targeting of Coagulation Factor XI Mitigates the Development of Experimental Atherosclerosis in Low-density Lipoprotein Receptor-deficient Mice
-
Abstract Number: PB0073
Selective Small Molecule Factor XIIa Inhibitor KV998083 Protects against FeCl3 Induced Arterial Thrombosis in Mice
-
Abstract Number: OC 54.2
Severe High Molecular Weight Kininogen (HK) Deficiency: Clinical Characteristics, and KNG1 Mutations in Reported and New Cases
-
Abstract Number: OC 54.4
Studying Factor XII Structure-function Relationships Using Factor XII-HGFA Chimeric Proteins
-
Abstract Number: PB0075
Titanium Compounds Bind and Activate Factor XII and Prekallikrein